BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 36549296)

  • 1. Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial.
    Ezpeleta M; Gabel K; Cienfuegos S; Kalam F; Lin S; Pavlou V; Song Z; Haus JM; Koppe S; Alexandria SJ; Tussing-Humphreys L; Varady KA
    Cell Metab; 2023 Jan; 35(1):56-70.e3. PubMed ID: 36549296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternate-Day Fasting Combined with Exercise: Effect on Sleep in Adults with Obesity and NAFLD.
    Ezpeleta M; Gabel K; Cienfuegos S; Kalam F; Lin S; Pavlou V; Varady KA
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986128
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial.
    Cai H; Qin YL; Shi ZY; Chen JH; Zeng MJ; Zhou W; Chen RQ; Chen ZY
    BMC Gastroenterol; 2019 Dec; 19(1):219. PubMed ID: 31852444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].
    Jia GY; Han T; Gao L; Wang L; Wang SC; Yang L; Zhang J; Guan YY; Yan NN; Yu HY; Xiao HJ; Di FS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):34-41. PubMed ID: 29804360
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.
    Golabi P; Locklear CT; Austin P; Afdhal S; Byrns M; Gerber L; Younossi ZM
    World J Gastroenterol; 2016 Jul; 22(27):6318-27. PubMed ID: 27468220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD.
    Oh S; Tsujimoto T; Kim B; Uchida F; Suzuki H; Iizumi S; Isobe T; Sakae T; Tanaka K; Shoda J
    JHEP Rep; 2021 Jun; 3(3):100253. PubMed ID: 33898958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.
    Zhang HJ; He J; Pan LL; Ma ZM; Han CK; Chen CS; Chen Z; Han HW; Chen S; Sun Q; Zhang JF; Li ZB; Yang SY; Li XJ; Li XY
    JAMA Intern Med; 2016 Aug; 176(8):1074-82. PubMed ID: 27379904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial.
    Wong VW; Chan RS; Wong GL; Cheung BH; Chu WC; Yeung DK; Chim AM; Lai JW; Li LS; Sea MM; Chan FK; Sung JJ; Woo J; Chan HL
    J Hepatol; 2013 Sep; 59(3):536-42. PubMed ID: 23623998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes.
    Shao N; Kuang HY; Hao M; Gao XY; Lin WJ; Zou W
    Diabetes Metab Res Rev; 2014 Sep; 30(6):521-9. PubMed ID: 24823873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electroacupuncture combined with lifestyle control on obese nonalcoholic fatty liver disease: a randomized controlled trial].
    Dong C; Zhang CR; Xue BY; Miu WF; Fang NY; Li K; Ou ZJ; Xu YQ
    Zhongguo Zhen Jiu; 2020 Feb; 40(2):129-34. PubMed ID: 32100496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.
    Sullivan S; Kirk EP; Mittendorfer B; Patterson BW; Klein S
    Hepatology; 2012 Jun; 55(6):1738-45. PubMed ID: 22213436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
    Aller R; Izaola O; Gómez S; Tafur C; González G; Berroa E; Mora N; González JM; de Luis DA
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3118-24. PubMed ID: 26367736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate-Intensity Aerobic vs Resistance Exercise and Dietary Modification in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.
    Charatcharoenwitthaya P; Kuljiratitikal K; Aksornchanya O; Chaiyasoot K; Bandidniyamanon W; Charatcharoenwitthaya N
    Clin Transl Gastroenterol; 2021 Mar; 12(3):e00316. PubMed ID: 33939383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternate Day Fasting Combined with a Low Carbohydrate Diet: Effect on Sleep Quality, Duration, Insomnia Severity and Risk of Obstructive Sleep Apnea in Adults with Obesity.
    Kalam F; Gabel K; Cienfuegos S; Ezpeleta M; Wiseman E; Varady KA
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33450908
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial.
    Khoo J; Hsiang J; Taneja R; Law NM; Ang TL
    Diabetes Obes Metab; 2017 Dec; 19(12):1814-1817. PubMed ID: 28503750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.
    Katsagoni CN; Georgoulis M; Papatheodoridis GV; Panagiotakos DB; Kontogianni MD
    Metabolism; 2017 Mar; 68():119-132. PubMed ID: 28183444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternate-day fasting protects the livers of mice against high-fat diet-induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling.
    Yang W; Cao M; Mao X; Wei X; Li X; Chen G; Zhang J; Wang Z; Shi J; Huang H; Yao X; Liu C
    Nutr Res; 2016 Jun; 36(6):586-93. PubMed ID: 27188904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of randomized controlled trials.
    Saleh SAK; Santos HO; Găman MA; Cerqueira HS; Zaher EA; Alromaih WR; Arafat NS; Adi AR; Adly HM; Alyoubi R; Alyahyawi N; Kord-Varkaneh H
    Clin Nutr ESPEN; 2024 Feb; 59():70-80. PubMed ID: 38220409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.